Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 4
2019 3
2020 12
2021 13
2022 11
2023 17
2024 31
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer.
Koehler VF, Achterfeld J, Sandner N, Koch C, Wiegmann JP, Ivanyi P, Käsmann L, Pusch R, Wolf D, Chirica M, Knösel T, Demes MC, Kumbrink J, Vogl TJ, Meyer G, Spitzweg C, Bojunga J, Kroiss M. Koehler VF, et al. J Cancer Res Clin Oncol. 2023 Nov;149(15):14035-14043. doi: 10.1007/s00432-023-05134-x. Epub 2023 Aug 7. J Cancer Res Clin Oncol. 2023. PMID: 37548775 Free PMC article.
CD74 is a functional MIF receptor on activated CD4+ T cells.
Zhang L, Woltering I, Holzner M, Brandhofer M, Schaefer CC, Bushati G, Ebert S, Yang B, Muenchhoff M, Hellmuth JC, Scherer C, Wichmann C, Effinger D, Hübner M, El Bounkari O, Scheiermann P, Bernhagen J, Hoffmann A. Zhang L, et al. Cell Mol Life Sci. 2024 Jul 11;81(1):296. doi: 10.1007/s00018-024-05338-5. Cell Mol Life Sci. 2024. PMID: 38992165 Free PMC article.
Adaptive pathfinding by nucleokinesis during amoeboid migration.
Kroll J, Hauschild R, Kuznetcov A, Stefanowski K, Hermann MD, Merrin J, Shafeek L, Müller-Taubenberger A, Renkawitz J. Kroll J, et al. EMBO J. 2023 Dec 11;42(24):e114557. doi: 10.15252/embj.2023114557. Epub 2023 Nov 21. EMBO J. 2023. PMID: 37987147 Free PMC article.
Myeloid cannabinoid CB1 receptor deletion confers atheroprotection in male mice by reducing macrophage proliferation in a sex-dependent manner.
Wang Y, Li G, Chen B, Shakir G, Volz M, van der Vorst EPC, Maas SL, Geiger M, Jethwa C, Bartelt A, Li Z, Wettich J, Sachs N, Maegdefessel L, Nazari Jahantigh M, Hristov M, Lacy M, Lutz B, Weber C, Herzig S, Guillamat Prats R, Steffens S. Wang Y, et al. Cardiovasc Res. 2024 Oct 14;120(12):1411-1426. doi: 10.1093/cvr/cvae125. Cardiovasc Res. 2024. PMID: 38838211 Free PMC article.
High-pressure synthesis of Ruddlesden-Popper nitrides.
Weidemann M, Werhahn D, Mayer C, Kläger S, Ritter C, Manuel P, Attfield JP, Kloß SD. Weidemann M, et al. Nat Chem. 2024 Oct;16(10):1723-1731. doi: 10.1038/s41557-024-01558-1. Epub 2024 Jun 25. Nat Chem. 2024. PMID: 38918580
Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapy.
Winkelmann M, Blumenberg V, Rejeski K, Quell C, Bücklein VL, Ingenerf M, Unterrainer M, Schmidt C, Dekorsy FJ, Bartenstein P, Ricke J, von Bergwelt-Baildon M, Subklewe M, Kunz WG. Winkelmann M, et al. Ann Hematol. 2024 Jan;103(1):259-268. doi: 10.1007/s00277-023-05507-9. Epub 2023 Oct 20. Ann Hematol. 2024. PMID: 37861736
Meropenem pharmacokinetics in cerebrospinal fluid: comparing intermittent and continuous infusion strategies in critically ill patients-a prospective cohort study.
Wicha SG, Kinast C, Münchow M, Wittova S, Greppmair S, Kunzelmann AK, Zoller M, Paal M, Vogeser M, Habler K, Weig T, Terpolilli N, Heck S, Dimitriadis K, Scharf C, Liebchen U. Wicha SG, et al. Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0045124. doi: 10.1128/aac.00451-24. Epub 2024 Jul 31. Antimicrob Agents Chemother. 2024. PMID: 39082803
86 results